Literature DB >> 22035042

State-of-the-art on basic and applied stem cell therapy; Stem Cell Research Italy-International Society for Cellular Therapy Europe, Joint Meeting, Montesilvano (PE)-Italy, June 10-12, 2011.

Dario Siniscalco, Assunta Pandolfi, Umberto Galderisi.   

Abstract

Over 160 stem cell-based therapeutic products are undergoing development for the treatment of several diseases, ranging from cardiac and artery diseases to immune and neurodegenerative pathologies, including diabetes, spinal cord injury. Therefore, stem cell therapy plays a key role for developing new cell-based drugs for the future molecular and regenerative medicine. The second meeting organized by Stem Cell Research Italy (SCR Italy) and by the International Society for Cellular Therapy-Europe (ISCT) in Montesilvano/Città S. Angelo (Pescara)-Italy, on June 10th-12th, 2011, focused on the state-of-the-art of stem cell therapy and associated novel findings on stem cell research ( www.stemcellitaly.org ).

Entities:  

Mesh:

Year:  2011        PMID: 22035042     DOI: 10.1089/scd.2011.0609

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  5 in total

Review 1.  Mesenchymal stem cells in treating autism: Novel insights.

Authors:  Dario Siniscalco; James Jeffrey Bradstreet; Nataliia Sych; Nicola Antonucci
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

Review 2.  Induced pluripotent stem cells as a cellular model for studying Down Syndrome.

Authors:  Anna Lisa Brigida; Dario Siniscalco
Journal:  J Stem Cells Regen Med       Date:  2016-11-29

Review 3.  Stem cell therapy in autism: recent insights.

Authors:  Dario Siniscalco; Suresh Kannan; Neomar Semprún-Hernández; Adrien A Eshraghi; Anna Lisa Brigida; Nicola Antonucci
Journal:  Stem Cells Cloning       Date:  2018-10-23

Review 4.  Perspectives on the use of stem cells for autism treatment.

Authors:  Dario Siniscalco; James Jeffrey Bradstreet; Nataliia Sych; Nicola Antonucci
Journal:  Stem Cells Int       Date:  2013-10-10       Impact factor: 5.443

5.  Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liver.

Authors:  David C Bartlett; James Hodson; Ricky H Bhogal; Janine Youster; Phil N Newsome
Journal:  Cytotherapy       Date:  2014-03-15       Impact factor: 5.414

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.